ULA Gears Up Vulcan Rocket to Challenge SpaceX's Starship

Published 1 days agoBA

ULA Gears Up Vulcan Rocket to Challenge SpaceX's Starship

United Launch Alliance (ULA), a collaboration between aerospace giants Boeing and Lockheed Martin, is planning significant enhancements to its Vulcan rocket. The goal is to better compete in the low Earth orbit (LEO) satellite launch market, currently dominated by SpaceX's formidable Starship. As reported by Reuters, ULA intends to create a Vulcan variant that's optimized for this burgeoning sector, tapping into the market being shaped by SpaceX’s Starlink operations.

Part of ULA's strategy involves introducing a new configuration called 'Vulcan Heavy.' This upgrade, which combines three Vulcan boosters, is designed to significantly boost the payload capacity for LEO missions. By enhancing the rocket's capabilities, ULA aims to provide a competitive alternative to SpaceX's offerings. All of this is slated to occur in tandem with SpaceX's timeline for Starship's LEO launches, which are expected to take place over the next several years.

In addition to these upgrades, the Vulcan rocket is already certified by the U.S. Space Force for national security missions, ensuring it will see multiple launches in the coming years. This certification reflects the Vulcan's reliability and its alignment with national priorities, providing ULA with a stable foundation as it looks to expand its market presence through these strategic enhancements.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Merck and Daiichi Sankyo Withdraw Lung Cancer Drug Application

Merck and Daiichi Sankyo Withdraw Lung Cancer Drug Application

9 minutes agoMRK

Merck and Daiichi Sankyo have decided to pull their U.S. application for the experimental lung cancer drug known as patritumab deruxtecan. This decision comes after the drug failed to show a survival benefit in a late-stage clinical trial, as reported by Reuters. The drug was aimed at treating patients with non-small cell lung cancer who had exhausted at least two other treatment options and possessed a particular gene mutation linked to abnormal cell growth. The drug, designed as a targeted therapy to attack cancer cells while sparing healthy ones, was expected to provide a new option for hard-to-treat cancer cases. However, the trial results did not meet expectations in demonstrating a clear survival advantage. This follows a previous setback when the U.S. Food and Drug Administration declined to approve the therapy due to manufacturing issues at a third-party facility. The withdrawal of the application is likely to have implications for Merck and Daiichi Sankyo's efforts in developing innovative cancer treatments. Both companies have been working together to advance targeted therapy options, and this development may impact their collaborative oncology pipeline and strategies.

Kohl's Posts Smaller Q1 Loss, Sticks to Full-Year Forecast

Kohl's Posts Smaller Q1 Loss, Sticks to Full-Year Forecast

24 minutes agoKSS

Kohl's Corporation surpassed analyst expectations with its first-quarter 2025 earnings report, announcing a smaller than anticipated loss. The company reported a loss of $0.13 per share, improving over its earlier estimate of a $0.20 to $0.24 loss and beating analysts' forecast of a $0.26 loss, Reuters reported. Even though comparable sales declined by 3.9%, this was slightly less severe than the predicted 4% to 4.3% drop. Kohl's is also maintaining its full-year sales outlook with projections of a 5% to 7% decline and anticipates annual earnings per share to range between $0.10 and $0.60. In response to the latest earnings news, Kohl's shares rose by 6% in premarket trading. Kohl's is committed to strategic changes, focusing on closing underperforming locations and bolstering its collaboration with Sephora. The retailer plans to expand its Sephora presence to over 1,100 mini-stores within Kohl's by the end of the year. These steps demonstrate the retailer's ongoing efforts to adapt and strengthen its market position.

Best Buy Lowers Sales Forecast Amid Tariff Challenges

Best Buy Lowers Sales Forecast Amid Tariff Challenges

39 minutes agoBBY

Best Buy has adjusted its financial outlook for the fiscal year 2026, primarily due to the impact of increased tariffs on electronics prices. The company now expects comparable sales to fluctuate between a decrease of 1% and an increase of 1%, revising its previous forecast from flat to 2% growth. This announcement led to a 3% drop in the company’s shares during premarket trading, Reuters reported. The change in outlook is largely attributed to U.S. tariffs on Chinese and Mexican imports, which are predicted to hike costs for high-ticket items like appliances, home theater systems, and gaming consoles. Given that a substantial portion of Best Buy’s inventory—including gaming consoles, audio equipment, cameras, and drones—comes from China, the company is particularly susceptible to these tariff-associated price increases. In addition to the revised forecast, Best Buy also reported a 0.7% decline in first-quarter same-store sales, surpassing analysts' expectations of a 0.6% drop. This situation underscores the ongoing challenges retailers face amid shifting trade policies and their effects on pricing structures for consumer electronics.

JetBlue and United Forge 'Blue Sky' Partnership to Boost Traveler Benefits

JetBlue and United Forge 'Blue Sky' Partnership to Boost Traveler Benefits

54 minutes agoUAL

JetBlue Airways and United Airlines have unveiled a new partnership named "Blue Sky" that aims to enhance travel options for customers of both airlines. A significant feature of this collaboration allows passengers to book flights seamlessly across both airlines' websites, as well as earn and redeem frequent flyer points interchangeably, as reported by Reuters. This move is geared toward offering more flexibility and value to travelers. Under the terms of the partnership, JetBlue is set to provide United with access to up to seven daily round-trip slots at New York's JFK Airport starting in 2027, contingent on U.S. regulatory approval. Additionally, the two airlines have agreed to swap eight flight slots at Newark Airport to boost connectivity. These developments are part of a wider strategy to expand access and conveniences for passengers flying with either airline. In line with enhancing the customer experience, frequent flyers with preferred status on either JetBlue or United will gain benefits such as seat upgrades and more flexible flight changes. Moreover, United plans to integrate some of its holiday and travel services with JetBlue's Paisly platform, streamlining travel offerings and potentially attracting a broader customer base. This partnership represents a significant step in both airlines' efforts to offer more comprehensive services.